Oliver Sartor, M.D.
Medical Director of the Tulane Cancer Center
C.E. and Bernadine Laborde Professor of Cancer Research
Professor, Department of Medicine: Section of Hematology & Medical Oncology and Department of Urology
TCC Program Member
osartor@tulane.edu
(504) 988-7869, (504) 988-5059 fax
1430 Tulane Ave., SL-42, New Orleans, LA 70112
Biographical information:
Dr. Oliver Sartor is the C.E. and Bernadine Laborde Professor of Cancer Research in the Departments of Medicine and Urology at Tulane University School of Medicine. He is a medical oncologist with an interest in prostate cancer from both a basic and clinical perspective. He is on the Department of Defense Integration Panel for prostate cancer research and is the chairman-elect of the organization as well as co-editor-in-chief of the peer-reviewed journal Clinical Genitourinary Cancer. He is also the current medical oncology chair of the Radiation Oncology Treatment Group Genitourinary Cancer Committee. In addition, Dr. Sartor is a SPORE project co-PI at Dana-Farber Cancer Center on a translational project involving the clinical outcomes and consequences of the 8q24 risk alleles. Dr. Sartor's current research interests include clinical trials in advanced prostate cancer with novel agents and novel combinations of agents. His collaborative projects include novel concepts in prostate stem cells and germ line assessment of prostate cancer risk.
Please click here to view Dr. Sartor's Publications
